<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The immunophenotypes of 74 malignant <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (9 Hodgkin's disease, 19 low-grade B-cell, 20 high-grade B-cell, 8 T-cell, and 18 large cell anaplastic <z:hpo ids='HP_0002665'>lymphomas</z:hpo> [LCAL]) have been characterized with antibodies against leucocyte differentiation antigens, keratin, and vimentin </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> the non-LCAL were CD45 positive and keratin negative </plain></SENT>
<SENT sid="2" pm="."><plain>The LCALs had a more varied immunophenotype, with CD45 present only in 11 of 18 cases and keratin present in 5 of 18 of these rare <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The lymphoid origin of these latter cases was proven by gene rearrangement studies </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> LCALs were CD30+, and, where tested, vimentin positive </plain></SENT>
<SENT sid="5" pm="."><plain>Of four different vimentin monoclonal antibodies tested, V9 and MVI stained the highest number of <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Positive staining of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells was seen in 61 of 71 cases </plain></SENT>
<SENT sid="7" pm="."><plain>Vimentin-negative cases included Burkitt's as well as some follicular <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
</text></document>